Effects of Insulin Detemir and NPH Insulin on Body Weight and Appetite-Regulating Brain Regions in Human Type 1 Diabetes: A Randomized Controlled Trial

被引:11
|
作者
van Golen, Larissa W. [1 ]
Veltman, Dick J. [2 ]
IJzerman, Richard G. [1 ]
Deijen, Jan Berend [3 ]
Heijboer, Annemieke C. [4 ]
Barkhof, Frederik [5 ]
Drent, Madeleine L. [3 ,6 ]
Diamant, Michaela [1 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Diabet Center, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Amsterdam, Netherlands
[5] Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands
[6] Vrije Univ Amsterdam, Med Ctr, Endocrine Sect, Dept Internal Med, Amsterdam, Netherlands
来源
PLOS ONE | 2014年 / 9卷 / 04期
关键词
REDUCES FOOD-INTAKE; GAIN; INFUSION; BEHAVIOR; HUNGER; REWARD;
D O I
10.1371/journal.pone.0094483
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Studies in rodents have demonstrated that insulin in the central nervous system induces satiety. In humans, these effects are less well established. Insulin detemir is a basal insulin analog that causes less weight gain than other basal insulin formulations, including the current standard intermediate-long acting Neutral Protamine Hagedorn (NPH) insulin. Due to its structural modifications, which render the molecule more lipophilic, it was proposed that insulin detemir enters the brain more readily than other insulins. The aim of this study was to investigate whether insulin detemir treatment differentially modifies brain activation in response to food stimuli as compared to NPH insulin. In addition, cerebral spinal fluid (CSF) insulin levels were measured after both treatments. Brain responses to viewing food and non-food pictures were measured using functional Magnetic Resonance Imaging in 32 type 1 diabetic patients, after each of two 12-week treatment periods with insulin detemir and NPH insulin, respectively, both combined with prandial insulin aspart. CSF insulin levels were determined in a subgroup. Insulin detemir decreased body weight by 0.8 kg and NPH insulin increased weight by 0.5 kg (p = 0.02 for difference), while both treatments resulted in similar glycemic control. After treatment with insulin detemir, as compared to NPH insulin, brain activation was significantly lower in bilateral insula in response to visual food stimuli, compared to NPH (p = 0.02 for right and p = 0.05 for left insula). Also, CSF insulin levels were higher compared to those with NPH insulin treatment (p = 0.003). Our findings support the hypothesis that in type 1 diabetic patients, the weight sparing effect of insulin detemir may be mediated by its enhanced action on the central nervous system, resulting in blunted activation in bilateral insula, an appetite-regulating brain region, in response to food stimuli.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Cerebral Blood Flow and Glucose Metabolism in Appetite-Related Brain Regions in Type 1 Diabetic Patients After Treatment With Insulin Detemir and NPH Insulin A randomized controlled crossover trial
    van Golen, Larissa W.
    IJzerman, Richard G.
    Huisman, Marc C.
    Hensbergen, Jolanda F.
    Hoogma, Roel P.
    Drent, Madeleine L.
    Lammertsma, Adriaan A.
    Diamant, Michaela
    [J]. DIABETES CARE, 2013, 36 (12) : 4050 - 4056
  • [2] A randomized controlled trial of insulin detemir versus insulin NPH for the treatment of pregnant women with gestational diabetes and type 2 diabetes
    Herrera, Kimberly
    Rosenn, Barak
    Foroutan, Janelle
    Bimson, Brianne
    Al Ibraheemi, Zainab
    Brustman, Lois
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2015, 212 (01) : S320 - S320
  • [3] Randomized controlled trial of insulin detemir versus NPH for the treatment of pregnant women with diabetes
    Herrera, Kimberly M.
    Rosenn, Barak M.
    Foroutan, Janelle
    Bimson, Brianne E.
    Al Ibraheemi, Zainab
    Moshier, Erin L.
    Brustman, Lois E.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2015, 213 (03)
  • [4] Maternal Efficacy and Safety Outcomes in a Randomized, Controlled Trial Comparing Insulin Detemir With NPH Insulin in 310 Pregnant Women With Type 1 Diabetes
    Mathiesen, Elisabeth R.
    Hod, Moshe
    Ivanisevic, Marina
    Duran Garcia, Santiago
    Brondsted, Lise
    Jovanovic, Lois
    Damm, Peter
    McCance, David R.
    [J]. DIABETES CARE, 2012, 35 (10) : 2012 - 2017
  • [5] Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes - A randomized clinical trial
    Home, P
    Bartley, P
    Russell-Jones, D
    Hanaire-Broutin, H
    Heeg, JE
    Abrams, P
    Landin-Olsson, M
    Hylleberg, B
    Lang, H
    Draeger, E
    [J]. DIABETES CARE, 2004, 27 (05) : 1081 - 1087
  • [6] Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes
    Robertson, K. J.
    Schoenle, E.
    Gucev, Z.
    Mordhorst, L.
    Gall, M. -A.
    Ludvigsson, J.
    [J]. DIABETIC MEDICINE, 2007, 24 (01) : 27 - 34
  • [7] Comparison of Insulin Glargine and Detemir Effects on Hormones of Appetite and Metabolic Control in Patients with Type 1 Diabetes: A Randomized Clinical Trial
    Razzaghy-Azar, Maryam
    Momeni, Hosein
    Nourbakhsh, Mona
    Nourbakhsh, Mitra
    Talebi, Atefeh
    Pourgholi, Gholamreza
    Zeinolabedinian, Fahimeh
    [J]. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2021, 20 (03): : 647 - 653
  • [8] Perinatal outcomes in pregnancy: a randomised trial comparing insulin detemir with NPH insulin in 310 subjects with type 1 diabetes
    Hod, M.
    McCance, D. R.
    Ivanisevic, M.
    Garcia, S.
    Jovanovic, L.
    Mathiesen, E. R.
    Damm, P.
    [J]. DIABETOLOGIA, 2011, 54 : S487 - S487
  • [9] A randomized trial of insulin aspart with intensified basal NPH insulin supplementation in type 1 diabetes
    DeVries, JH
    Lindholm, A
    Heine, RJ
    Home, PD
    [J]. DIABETOLOGIA, 2001, 44 : A209 - A209
  • [10] A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes
    Home, PD
    Rosskamp, R
    Forjanic-Klapproth, J
    Dressler, A
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (06) : 545 - 553